11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma

Tetsuhiro Hatakeyama, Nobuyuki Kawai, Yoshihiro Nishiyama, Yuka Yamamoto, Yasuhiro Sasakawa, Tomotsugu Ichikawa, Takashi Tamiya

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Purpose: The purpose of this prospective study was to clarify the individual and combined role of l-methyl-11C-methionine-positron emission tomography (MET-PET) and 3′-deoxy-3′-[18F] fluorothymidine (FLT)-PET in tumor detection, noninvasive grading, and assessment of the cellular proliferation rate in newly diagnosed histologically verified gliomas of different grades. Materials and methods: Forty-one patients with newly diagnosed gliomas were investigated with MET-PET before surgery. Eighteen patients were also examined with FLT-PET. MET and FLT uptakes were assessed by standardized uptake value of the tumor showing the maximum uptake (SUVmax), and the ratio to uptake in the normal brain parenchyma (T/N ratio). All tumors were graded by the WHO grading system using surgical specimens, and the proliferation activity of the tumors were determined by measuring the Ki-67 index obtained by immunohistochemical staining. Results: On semiquantitative analysis, MET exhibited a slightly higher sensitivity (87.8%) in tumor detection than FLT (83.3%), and both tracers were 100% sensitive for malignant gliomas. Low-grade gliomas that were false negative on MET-PET also were false negative on FLT-PET. Although the difference of MET SUVmax and T/N ratio between grades II and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Low-grade gliomas with oligodendroglial components had relatively high MET uptake. The difference of FLT SUVmax and T/N ratio between grades III and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Grade III gliomas with non-contrast enhancement on MR images had very low FLT uptake. In 18 patients who underwent PET examination with both tracers, a significant but relatively weak correlation was observed between the individual SUVmax of MET and FLT (r=0.54, P

Original languageEnglish
Pages (from-to)2009-2017
Number of pages9
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume35
Issue number11
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Glioma
Methionine
Neoplasms
Positron-Emission Tomography
Cell Proliferation
Prospective Studies
Staining and Labeling
Brain

Keywords

  • C- methionine
  • F-fluorothymidine
  • Cellular proliferation
  • Glioma
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. / Hatakeyama, Tetsuhiro; Kawai, Nobuyuki; Nishiyama, Yoshihiro; Yamamoto, Yuka; Sasakawa, Yasuhiro; Ichikawa, Tomotsugu; Tamiya, Takashi.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 11, 11.2008, p. 2009-2017.

Research output: Contribution to journalArticle

Hatakeyama, T, Kawai, N, Nishiyama, Y, Yamamoto, Y, Sasakawa, Y, Ichikawa, T & Tamiya, T 2008, '11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma', European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 11, pp. 2009-2017. https://doi.org/10.1007/s00259-008-0847-5
Hatakeyama, Tetsuhiro ; Kawai, Nobuyuki ; Nishiyama, Yoshihiro ; Yamamoto, Yuka ; Sasakawa, Yasuhiro ; Ichikawa, Tomotsugu ; Tamiya, Takashi. / 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. In: European Journal of Nuclear Medicine and Molecular Imaging. 2008 ; Vol. 35, No. 11. pp. 2009-2017.
@article{ce850572adac4de09706162b4dcd4a2a,
title = "11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma",
abstract = "Purpose: The purpose of this prospective study was to clarify the individual and combined role of l-methyl-11C-methionine-positron emission tomography (MET-PET) and 3′-deoxy-3′-[18F] fluorothymidine (FLT)-PET in tumor detection, noninvasive grading, and assessment of the cellular proliferation rate in newly diagnosed histologically verified gliomas of different grades. Materials and methods: Forty-one patients with newly diagnosed gliomas were investigated with MET-PET before surgery. Eighteen patients were also examined with FLT-PET. MET and FLT uptakes were assessed by standardized uptake value of the tumor showing the maximum uptake (SUVmax), and the ratio to uptake in the normal brain parenchyma (T/N ratio). All tumors were graded by the WHO grading system using surgical specimens, and the proliferation activity of the tumors were determined by measuring the Ki-67 index obtained by immunohistochemical staining. Results: On semiquantitative analysis, MET exhibited a slightly higher sensitivity (87.8{\%}) in tumor detection than FLT (83.3{\%}), and both tracers were 100{\%} sensitive for malignant gliomas. Low-grade gliomas that were false negative on MET-PET also were false negative on FLT-PET. Although the difference of MET SUVmax and T/N ratio between grades II and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Low-grade gliomas with oligodendroglial components had relatively high MET uptake. The difference of FLT SUVmax and T/N ratio between grades III and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Grade III gliomas with non-contrast enhancement on MR images had very low FLT uptake. In 18 patients who underwent PET examination with both tracers, a significant but relatively weak correlation was observed between the individual SUVmax of MET and FLT (r=0.54, P",
keywords = "C- methionine, F-fluorothymidine, Cellular proliferation, Glioma, Positron emission tomography",
author = "Tetsuhiro Hatakeyama and Nobuyuki Kawai and Yoshihiro Nishiyama and Yuka Yamamoto and Yasuhiro Sasakawa and Tomotsugu Ichikawa and Takashi Tamiya",
year = "2008",
month = "11",
doi = "10.1007/s00259-008-0847-5",
language = "English",
volume = "35",
pages = "2009--2017",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma

AU - Hatakeyama, Tetsuhiro

AU - Kawai, Nobuyuki

AU - Nishiyama, Yoshihiro

AU - Yamamoto, Yuka

AU - Sasakawa, Yasuhiro

AU - Ichikawa, Tomotsugu

AU - Tamiya, Takashi

PY - 2008/11

Y1 - 2008/11

N2 - Purpose: The purpose of this prospective study was to clarify the individual and combined role of l-methyl-11C-methionine-positron emission tomography (MET-PET) and 3′-deoxy-3′-[18F] fluorothymidine (FLT)-PET in tumor detection, noninvasive grading, and assessment of the cellular proliferation rate in newly diagnosed histologically verified gliomas of different grades. Materials and methods: Forty-one patients with newly diagnosed gliomas were investigated with MET-PET before surgery. Eighteen patients were also examined with FLT-PET. MET and FLT uptakes were assessed by standardized uptake value of the tumor showing the maximum uptake (SUVmax), and the ratio to uptake in the normal brain parenchyma (T/N ratio). All tumors were graded by the WHO grading system using surgical specimens, and the proliferation activity of the tumors were determined by measuring the Ki-67 index obtained by immunohistochemical staining. Results: On semiquantitative analysis, MET exhibited a slightly higher sensitivity (87.8%) in tumor detection than FLT (83.3%), and both tracers were 100% sensitive for malignant gliomas. Low-grade gliomas that were false negative on MET-PET also were false negative on FLT-PET. Although the difference of MET SUVmax and T/N ratio between grades II and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Low-grade gliomas with oligodendroglial components had relatively high MET uptake. The difference of FLT SUVmax and T/N ratio between grades III and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Grade III gliomas with non-contrast enhancement on MR images had very low FLT uptake. In 18 patients who underwent PET examination with both tracers, a significant but relatively weak correlation was observed between the individual SUVmax of MET and FLT (r=0.54, P

AB - Purpose: The purpose of this prospective study was to clarify the individual and combined role of l-methyl-11C-methionine-positron emission tomography (MET-PET) and 3′-deoxy-3′-[18F] fluorothymidine (FLT)-PET in tumor detection, noninvasive grading, and assessment of the cellular proliferation rate in newly diagnosed histologically verified gliomas of different grades. Materials and methods: Forty-one patients with newly diagnosed gliomas were investigated with MET-PET before surgery. Eighteen patients were also examined with FLT-PET. MET and FLT uptakes were assessed by standardized uptake value of the tumor showing the maximum uptake (SUVmax), and the ratio to uptake in the normal brain parenchyma (T/N ratio). All tumors were graded by the WHO grading system using surgical specimens, and the proliferation activity of the tumors were determined by measuring the Ki-67 index obtained by immunohistochemical staining. Results: On semiquantitative analysis, MET exhibited a slightly higher sensitivity (87.8%) in tumor detection than FLT (83.3%), and both tracers were 100% sensitive for malignant gliomas. Low-grade gliomas that were false negative on MET-PET also were false negative on FLT-PET. Although the difference of MET SUVmax and T/N ratio between grades II and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Low-grade gliomas with oligodendroglial components had relatively high MET uptake. The difference of FLT SUVmax and T/N ratio between grades III and IV gliomas was statistically significant (Pmax and T/N ratio between grades II and III gliomas was not statistically significant. Grade III gliomas with non-contrast enhancement on MR images had very low FLT uptake. In 18 patients who underwent PET examination with both tracers, a significant but relatively weak correlation was observed between the individual SUVmax of MET and FLT (r=0.54, P

KW - C- methionine

KW - F-fluorothymidine

KW - Cellular proliferation

KW - Glioma

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=53649106038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649106038&partnerID=8YFLogxK

U2 - 10.1007/s00259-008-0847-5

DO - 10.1007/s00259-008-0847-5

M3 - Article

C2 - 18542957

AN - SCOPUS:53649106038

VL - 35

SP - 2009

EP - 2017

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 11

ER -